SCHEMBL702270

SCHEMBL702270

O=CC1(c2cccc(F)c2)CCN(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.41
USP2 O75604 10/20 0.41
CYP1A2 P05177 6/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 3/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
CYP2D6 P10635 7/20 0.41
ALDH1A1 P00352 7/20 0.41
HIF1A Q16665 2/20 0.41
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
TSHR P16473 4/20 0.39
HSD11B1 P28845 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531048 0.84 KMT2A (0.45) USP2MEN1KMT2AMAPK1OPRM1
SCHEMBL704090 0.83 KMT2A (0.41) MEN1KMT2AOPRM1OPRD1OPRK1
SCHEMBL12510131 0.83 KDM1A (0.47) OPRM1OPRD1OPRK1OPRL1HSD11B1
SCHEMBL701324 0.81 GPR119 (0.46) CYP1A2OPRD1OPRK1CYP2D6ALDH1A1
SCHEMBL3441859 0.81 OPRM1 (0.60) CYP3A4USP2CYP1A2MEN1KMT2A
SCHEMBL626023 0.79 KDM1A (0.43) OPRM1OPRD1OPRK1OPRL1HSD11B1
SCHEMBL434934 0.77 SLC6A4 (0.49) OPRM1OPRD1OPRK1OPRL1TSHR
SCHEMBL11702985 0.75 PDE4A (0.43) MEN1KMT2AOPRM1OPRD1OPRK1
SCHEMBL17707495 0.75 OPRM1 (0.47) CYP3A4USP2CYP1A2MEN1KMT2A
SCHEMBL2200793 0.73 CYP3A4 (0.46) CYP3A4USP2CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
EP-2262791-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-12-22 EP disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124734-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 CYP3A4 750/4885USP2 3984/4885CYP1A2 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.